Bolstering its prospects of getting cardiovascular franchise, Swiss company Novartis is going to seek approval for an experimental heart failure treatment sooner than it had expected. An independent panel has recommended Novartis to close a late-stage trial for a twice-a-day pill LCZ696 after the clinical trial results showed patients taking the drug lived longer without being … [Read more...]
You are here: Home / Archives for Novartis Heart Failure Drug